Bioventus, Inc. Class A BVS 深 滬
已收盤 02-06 16:00:00 美东时间
8.51
+0.300
+3.65%
華盛通- 最 高8.53
- 今 開8.27
- 成交量 25.31万股
- 最 低 8.26
- 昨 收 8.21
- 總市值 7.04亿
- 52周最高 11.25
- 市盈率 靜 --
- 換手率 0.31%
- 52周最低 5.81
- 委 比 95.66%
- 總股本 8276.32万
- 歷史最高 19.941
- 量 比 0.80
- 振 幅 3.29%
- 歷史最低 0.7999
- 每 手 1
- 風險率 1.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference
Bioventus Inc. CEO Rob Claypoole will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, at 12:45 p.m. ET. The live webcast, including Q&A, will be available on the Investors section of Bioventus' website and can be replayed until February 14, 2026. Bioventus specializes in clinically proven, cost-effective products for active healing, with offerings in Pain Treatments, Restorative Therapies, and Surgical Solutions.
01-06 12:30
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference
Bioventus Inc. CEO Rob Claypoole will present at the Piper Sandler Healthcare Conference on December 3, 2025. The presentation, available via live webcast on Bioventus' website, includes a Q&A session and will be archived for later viewing. Bioventus provides evidence-based, cost-effective healing solutions and innovations for pain, restorative therapies, and surgical care.
2025-11-25 21:15
Bioventus surges on Q3 beats
Bioventus (BVS) is up ~19% in Tuesday trading after posting Q3 financial results that beat on both lines. While net sales change year-over-year was essentially flat due to a ~29% decline in its rest...
2025-11-05 01:36
Bravura Solutions Updates Constitution Following Shareholder Approval
An announcement from Bravura Solutions Limited ( ($AU:BVS) ) is now available. ...
2025-10-15 11:48
Bravura Solutions Announces Cessation of Securities
The latest update is out from Bravura Solutions Limited ( ($AU:BVS) ). Bravura ...
2025-10-13 06:18
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Bioventus Inc. announced that Mark Singleton, its Senior Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on September 10, 2025, at 1:05 p.m. ET. The presentation will be available via live webcast on the Company’s website and for replay afterward. Bioventus delivers clinically proven, cost-effective products to help patients heal quickly and safely, with a focus on...
2025-09-03 11:30
Bravura Solutions Announces 2025 AGM Date and Director Elections
The latest update is out from Bravura Solutions Limited ( ($AU:BVS) ). Bravura ...
2025-08-20 13:37
Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference
Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, announced that CEO Rob Claypoole will participate in a fireside chat at the Canaccord Genuity Global Growth Conference on August 12, 2025, at 2:00 p.m. ET. A live webcast with a Q&A session will be available on the company’s website, www.bioventus.com, followed by a replay.
2025-08-07 20:15
Bioventus Q2 Adj. EPS $0.21, Inline, Sales $147.660M Beat $146.284M Estimate
Bioventus (NASDAQ:BVS) reported quarterly earnings of $0.21 per share which met the analyst consensus estimate. This is a 31.25 percent increase over earnings of $0.16 per share from the same period last year. The
2025-08-06 19:03
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity
Bioventus Inc. has entered into a $400 million Senior Secured Credit Agreement, including a $300 million term loan and a $100 million revolving credit facility, maturing on July 31, 2030. The agreement enhances liquidity, reduces the applicable interest margin by 75 basis points, and lowers annual term loan amortization from 10% to 5%. Proceeds were used to repay $333 million under the previous 2019 Credit Agreement, with $30 million from the new...
2025-08-04 12:00
